253273-90-4 Usage
Uses
Used in Pharmaceutical Research:
3-[3-(Bromomethyl)phenyl]-5-methyl-1,2,4-oxadiazole is utilized as a pharmaceutical agent for its diverse biological activities, such as antifungal, antimicrobial, and cytotoxic properties. Its unique structure allows it to target specific biological pathways, making it a promising candidate for the development of new drugs to combat various diseases.
Used in Organic Synthesis:
In the field of organic synthesis, 3-[3-(Bromomethyl)phenyl]-5-methyl-1,2,4-oxadiazole serves as a key building block for the creation of a wide array of organic compounds. Its bromomethylphenyl group can be further functionalized, enabling the synthesis of complex molecules with specific properties and applications.
Used in Chemical Research:
3-[3-(Bromomethyl)phenyl]-5-methyl-1,2,4-oxadiazole is also employed in chemical research to explore its potential applications in various industries. Its unique structure and properties make it an interesting subject for studies aimed at uncovering new uses and understanding its reactivity and interactions with other molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 253273-90-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,3,2,7 and 3 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 253273-90:
(8*2)+(7*5)+(6*3)+(5*2)+(4*7)+(3*3)+(2*9)+(1*0)=134
134 % 10 = 4
So 253273-90-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H9BrN2O/c1-7-12-10(13-14-7)9-4-2-3-8(5-9)6-11/h2-5H,6H2,1H3
253273-90-4Relevant academic research and scientific papers
BENZOTHIAZOLONE DERIVATIVES
-
Page/Page column 25, (2011/11/12)
Compounds of the formula I, in which R1, R2, R3, R3′, R4, R4′, E, E′, E″ and E′″ have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and ca
N-aryl heterocycles via coupling reactions with arylboronic acids
Mederski, Werner W.K.R.,Lefort, Marina,Germann, Martina,Kux, Dieter
, p. 12757 - 12770 (2007/10/03)
Compounds having a partial 2-pyridone structure or 3-pyridazinones can be selectively N-arylated with phenylboronic acids according to the procedure described by Chan and Lam. This procedure leads to N5-arylated imidazo[4,5- c]pyridin-4-ones, precursors of potent factor Xa inhibitors. In addition, the synthesis of N-aryl substituted pyrrole- and indole-2-carboxylic acid esters is described. In the indole series this procedure offers a flexible entry in the synthesis of different 1,3-diaryl-2-carboxyindoles.
